A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14656566.2015.1067682
Reference101 articles.
1. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2. TORCH and UPLIFT: What Has Been Learned from the COPD “Mega-Trials”?
3. Understanding the GOLD 2011 Strategy as applied to a real-world COPD population
4. Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping
5. Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary Disease
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study;Archivos de Bronconeumología;2022-10
2. Eosinophilic Chronic Obstructive Pulmonary Disease;Lung;2021-11-05
3. The Use of Inhaled Corticosteroids for Patients with COPD Who Continue to Smoke Cigarettes: An Evaluation of Current Practice;The American Journal of Medicine;2021-10
4. Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study;Respiratory Research;2021-01-21
5. Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline;European Respiratory Journal;2020-05-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3